Platelet aggregation is initiated by the release of mediators as ADP stored in platelet granules.
INTRODUCTION
The critical role played by platelets in hemostasis and thrombosis is related to their function as exocytotic cells that secrete effector molecules at the side of vascular injury. Platelets contain at least 3 types of intracellular granules, in which these mediators are stored and concentrated, known as alpha, dense and lysosomal granules. 1 While alpha granules contain mainly polypeptides, as fibrinogen, von Willebrandt factor, growth factors and protease inhibitors, dense granules contain small molecules specifically ADP, ATP, serotonin, and calcium. 2 Humans with defective dense granule exocytosis suffer from delta storage pool disease associated with a moderate bleeding tendency. The most severe delta storage pool disease is observed in Hermansky-Pudlak syndrome (HPS), a rare autosomal recessive disorder in which oculocutaneous albinism, bleeding, and lysosomal ceroid storage result from defects of melanosomes, platelet-dense granules, and lysosomes. [3] [4] [5] Little is known, however, about transport proteins mediating accumulation of the effector molecules in granules or their transport across the plasma membrane. Possible candidates include the multidrug resistance protein 4 (MRP4/ABCC4) and MRP5 (ABCC5). These belong to the Cbranch of the human ATP-binding cassette (ABC) transporter superfamily which consists of 12 members; 9 of which comprise the group of multidrug resistance proteins (MRP1-9;
ABCC1-6 and ABCC10-12). 6, 7 MRPs are integral membrane glycoproteins which mediate the primary active unidirectional export of organic anions from cells. Conjugates of lipophilic compounds with glutathione, glucuronate and sulfate are preferred substrates of MRP1-3, [8] [9] [10] while cyclic purine nucleotides and nucleotide analogs have been identified as substrates for MRP4 and MRP5. [11] [12] [13] [14] [15] MRP5 mRNA has been detected in many tissues 16, 17 and the MRP5 protein could be localized in erythrocytes, 12 in smooth muscle cells of the genitourinary tract, 18 and in human heart cardiomyocytes, vascular endothelial, and smooth muscle cells.
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MRP4 mRNA was detected in prostate, liver, testis, ovary, brain, kidney and adrenal gland. 16, [20] [21] [22] Studies in membrane vesicles containing recombinant MRP4 indicate that it represents a transporter with relatively broad substrate spectrum including cyclic nucleotides as well as bile acids in cotransport with reduced glutathione, and prostaglandins. 14, 15, [22] [23] [24] [25] It confers also resistance to antiviral nucleoside analogs and cytotoxic thiopurine nucleosides probably by the cellular export of the intracellularly formed respective nucleotide. 11, 14, [26] [27] [28] Proceeding from the initial finding that MRP4 is highly expressed in human platelets, we investigated the subcellular localization and function of MRP4 in these blood cells. The results indicate a function of MRP4 in platelet dense granule storage and shed light on a novel 
HPS Patient
The patient is a member of a large kindred with the Hermansky-Pudlak syndrome, extensively studied as described before. 3, 4 He is an albino with white skin, numerous freckles, marked nystagmus, severely impaired vision, and a bleeding tendency characterized with easy bruising, gingival bleeding, and bleeding after tooth extraction. He has a prolonged bleeding time and a severe deficiency of granule-bound ATP and ADP in the platelets. 29 A mutation in the HPS4 gene has been found in this patient.
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Isolation of human platelets. Preparation of human platelets for membrane studies: Platelets were obtained from a normal donor, who did not take any medication during the previous two weeks by double arm cytapheresis using a Fresenius AS104 (Fresenius, Bad Homburg, Germany) separator using the C4F Plt 5d set, adenine-citrate dextrose (Fresenius, Bad Homburg, Germany) as an anticoagulant and saline 0.9% (Braun, Melsungen, Germany). The platelet concentrate was then filtered via a leukocyte depletion filter (> 99.999% reduction of leukocytes). By cell counting using the Nagotte chamber and flow cytometry, leukocyte contamination > 1/µl was excluded. For immunohistochemical studies, platelet-rich plasma (PRP) was isolated from citrated blood by differential centrifugation (180 x g, 20 min).
Washing of platelets. PRP was centrifuged (7 min, 650 x g) after addition of 111 µL/mL ACD-A and 5 µL apyrase/mL PRP. The supernatant was discarded and the platelets were washed with buffer containing 5 U/mL apyrase (Sigma, Taufkirchen, Germany) and 2 U/mL of hirudin (Pharmion GmbH, Hamburg, Germany). Finally the platelets were resuspended in
2 mmol/L CaCl 2 , 5.5 mmol/L D-glucose and 1 mg/mL BSA, pH 7,4). To follow the granule purification and enrichment, part of the platelets were incubated for 30 min at 37°C with mepacrine (100 µmol/L) and washed twice before lysis. Mepacrine accumulation in the obtained subcellular fractions was analyzed by fluorescence detection (excitation at 485 nm, emission at 535 nm). Activity of β-glucuronidase was measured as described previously 33 .
Immunoblot Analysis. Membrane fractions were loaded onto a 7.5 % sodium dodecylsulfatepolyacrylamid gel after incubation in sample buffer at 37 °C for 30 min. Immunoblotting was performed using a tank blotting system (Bio-Rad, Hercules, CA, USA) and an enhanced Tyrode buffer before they were placed on coverslips.
For comparison of normal platelets and Hermansky-Pudlak syndrome platelets, staining intensities were assessed by immunofluorescence microscopy using MetaMorph Imaging series 4.6 software (Visitron Systems GmbH, Puchheim, Germany).
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Results

Detection of MRP4 in human platelets
Expression of MRP4 and MRP5 was analyzed by immunoblot analysis as shown in Fig. 1A .
The SNG antibody directed against the carboxyl terminus of human MRP4 detected a strong broad double-band at 170-180 kDa in crude membranes (100,000 x g pellets) from human platelets ( The platelet crude membranes were further separated on a linear sucrose density gradient according to Broekman et al. 32 . After ultracentrifugation visible bands were obtained in basically the same density zones and with similar marker enzyme distribution as described in the reference. Four density zones enriched in plasma membrane (1), lysosomes (2), α-granules (3), or dense granules (4) 32 were further analyzed (Fig. 1B) . MRP4 was detected by immunoblotting and ATP-dependent cGMP transport as indication to MRP4 transport activity (see below) was measured. As marker of the different subcellular compartments antibodies against GPIb, LAMP2, and P-selectin as well as detection of β-glucuronidase activity and mepacrine accumulation were used. Fraction 4 exhibited the highest MRP4 antibody detection and cGMP transport activity, followed by fraction 1. Similar results were obtained using the
MLP antiserum directed against the amino terminus of MRP4 (not shown). The α-granule
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From marker, P-selectin, was highest in fraction 3, where MRP4 detection was lowest. The major platelet surface antigen GPIb (CD42b) was most abundant in fraction 1 and 2 but traces were also present in fraction 4. LAMP2 (Lysosome-Associated Membrane Glycoprotein 2), a marker for dense granules and lysosomes 34 , peaked in fraction 4 and in fraction 2, the fraction of major β-glucuronidase activity. This fraction seems to be a mixed fraction containing lysosomes but also a high proportion of plasma membrane, as indicated by GPIb.
Accumulation of the fluorescent mepacrine was used as an additional dense granule marker.
Mepacrine has been shown to be rapidly and specifically concentrated in dense granules. 35 Labeling appeared only in the densest fraction. However, note that here the intact platelets were loaded with mepacrine prior to homogenization and thus, transport into membrane vesicles, formed during the preparation, could not occur, in contrast to the cGMP transport measured in the isolated fractions.
Immunolocalization of MRP4 in human platelets
The subcellular localization of MRP4 in human platelets was further investigated using immunofluorescence microscopy ( Fig.2 and 3 ). As shown in Fig.2 , both anti-MRP4
antibodies SNG, directed against the carboxyl terminus, and MLP, directed against the amino terminus of MRP4, revealed a similar positive staining mainly in intracellular structures and to a lower extent at the plasma membrane depending on the activation of the platelets indicated by the different shape of platelets ( Fig.2A, C, E ). Control staining with the preimmune sera or after preincubation with the recognition peptide indicates the specificity of the signal ( Fig. 2 B, D, F) . To identify the intracellular structures, where MRP4 is localized, double-label experiments were performed using co-staining with P-selectin as marker for α-granules and mepacrine, as well as the anti-LAMP2 antibody, as markers for dense granules (Fig. 3) . The overlay images in Fig.3 (C, F, I ) indicate no co-localization with the α-granule
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From marker but a partial co-localization with mepacrine-storing and LAMP2-positive structures, most likely to be dense granules (Fig. 3 D-I ).
Altered localization of MRP4 in dense granules-deficient platelets (HPS)
Furthermore, the distribution of MRP4 in platelets from a patient with HPS was studied. It has been established before, that the patient had a severe deficiency of granule-bound ATP (0.08 µmol / 1011 platelets, controls 2.02 ±0.20) and granule-bound ADP (0.06 µmol/ 1011 platelets, controls 1.74 ± 0.21) 29 . Immunofluorescence microscopy of permeabilized and nonpermeabilized platelets from this patient revealed surface-expression of MRP4 with decreased intracellular staining compared to controls (Fig. 4) . By immunoblot analysis of whole platelet lysates, MRP4 was also found in HPS platelets most likely due to the plasma membrane expressed MRP4 (not shown). 
MRP4 transport activity in vesicular fractions from platelets
Discussion
The release of platelet-dense body constituents such as ADP has a fundamental role in hemostasis. The content in platelet dense bodies is probably established in megakaryocytes, with ADP concentrations exceeding 0.6 mol/L and indicating an active transport. However, very little is known about this process. The presence of plasma membrane proteins like GPIb in the dense granule membrane suggests that dense granules arise from both endogenous syntheses in the megakaryocyte as well as from heterotypic fusion with endocytic vesicles budding from the plasma membrane. 36 The present study identifies MRP4 as a major candidate for the active transport of organic anions, especially nucleotides, into these granules. This is based on the following observations: Immunoblotting ( Fig. 1 ) and immunofluorscence microscopy ( Fig.2-4) showed the high abundance of MRP4 in platelets and its predominate localization in dense granules as indicated by co-localization with mepacrine, which is specifically concentrated in dense granules 35 ( Fig. 3) , as well as by the altered distribution in platelets from a patient with Hermansky-Pudlak syndrome (HPS) (Fig.   4 ). Mutations in different genetic loci have been identified in patients with HPS 5, 37 and in strains of animals demonstrating HPS-like storage pool defects such as pale-ear mice. 38 Although the relationships between the genetic defects and the molecular pathogenesis are not yet fully defined, the normal development of platelet dense granules, which is related to lysosomal vesicle trafficking, is diminished leading to reduced or absent platelet dense granules. Our immunodetection of MRP4 in these granules (besides the plasma membrane and possibly other not identified intracellular membranes) is supported by functional studies demonstrating ATP-dependent transport of 3 H-labeled cGMP, which paralleled MRP4 detection in subcellular fractionation (Fig. 1B) . This transport proceeds into the fraction of inside-out membrane vesicles formed from the plasma membrane during the vesicle preparation as well as into the granules representing "preformed" inside-out vesicles (Fig. 8) .
Despite an unavoidable activation of the platelets during the homogenization procedure
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From leading to fusion of granules with the plasma membrane and the incomplete organelle separation, the relative distribution of MRP4 and cGMP transport in comparison with that of the other marker proteins indicates an enrichment in dense granules besides the plasma membrane fraction. Furthermore, the inhibition profile of the observed transport (Fig. 6) points at MRP4 as major candidate for mediating this process. The determined IC 50 values of 12 µM, 22 µM, and 43 µM for dipyridamole, indomethacin, and MK571, respectively, were slightly higher but in the same order of magnitude than those that have been found to inhibit MRP4-mediated transport in other systems. In membranes from MRP4-containing Sf9 cells 5 µM of indomethacin inhibited transport to about 50% 25 . MRP4-mediated PMEA efflux from intact cells was inhibited by dipyridamole and MK571 with an IC 50 value of 2 µM and 10 µM, respectively 24 . Amongst the MRPs, MRP4 has a unique broad substrate and inhibitor specificity. The leukotriene antagonist MK571 inhibits also effectively MRP1 9 , which, however, does not transport cyclic nucleotides. MRP5, a cyclic nucleotide transporter like MRP4 12 , is inhibited by dipyridamole but not or only slightly affected by MK571 12, 24 . Thus, the combined inhibition by dipyridamole, MK571 and indomethacin strongly argues for a major contribution of MRP4. In addition, we detected MRP5 only at a low level in platelets (Fig. 1A) . However, we can not fully exclude a contribution of other not yet identified proteins to the observed transport.
Dipyridamole and in particular dipyridamole in combination with low-dose aspirin are very effective in preventing recurrent stroke. 39 However, the mechanisms underlying this dipyridamole effect have not been fully elucidated. Dipyridamole has been shown to enhance NO/cGMP-mediated effects in intact human platelets 40 as well as to interfere with the ADPdependent platelet activation. 41 Both effects could be related to MRP4, assuming a possible effect of this transporter on the cytosolic cGMP concentration 28 Beside ADP and ATP, serotonin is also a well established compound of platelet dense granules. Platelets exhibit a sodium-and chloride-coupled serotonin uptake transporter (5-HTT; SLC6A4) in their plasma membrane. 42 In addition, a pH gradient-dependent serotonin transport system as been described in platelet dense granules 43 , however, the molecular identity of this transporter has not been elucidated so far. (Fig. 7) . This vanadatesensitive uptake of [ 3 H]ADP was markedly reduced by an increase in osmolarity of the extravesicular medium, which is expected to decrease the intravesicular volume without affecting the surface, suggesting that this process reflects transport into an osmotically sensitive space rather than binding to the membrane surface. Furthermore, this uptake was significantly affected by dipyridamole, MK571 and cGMP (Tab. 1). These data indicate the presence of an ATP-driven ADP transporting system in platelet membrane vesicles and granules and pinpoint MRP4 as a major candidate protein involved in this process.
The novel concept of the involvement of an ABC transporter in platelet transmitter storage and release (Fig.7) remains to be speculative but is strongly supported by our findings. This For (2), α-granules (3), or dense granules (4) according to Broekman et al. 32 were further analyzed. MRP4 was detected by immunoblotting using the antiserum SNG (20 µg protein/lane). Blots were further incubated with specific antibodies against LAMP2 (lysosome-associated membrane glycoprotein 2), P-selectin, and the surface antigen GPIb (CD42b), as marker for lysosomes/dense granules, α-granules, and plasma membrane, respectively (left panels). The results were quantified by densitometric analysis and the relative optical density of the specific bands was plotted (middle panels). Right panels: ATPdependent cGMP transport as well as mepacrine accumulation and β-glucuronidase activity were measured in the fractions as described in the Methods section and plotted as relative specific activities (mean values ± S.D., n = 3).
For personal use only. on August 31, 2017. by guest www.bloodjournal.org From Figure 2 . Immunofluorescence microscopy analysis of MRP4 in human platelets. Platelets were adhered on collagen, fixed, permeabilized and incubated with the primary anti-MRP4 antibodies SNG (A,C) and MLP (E) or, as control, with the respective pre-immune sera (B, F). D: Staining with SNG after preincubation with the synthetic peptide used to generate the SNG antiserum. Images were obtained by confocal laser scanning microscopy using a Alexa488-conjugated antirabbit secondary antibody and identical parameters for each set. 
